Essex Woodlands Management as of Dec. 31, 2019
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 8 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eyepoint Pharmaceuticals | 30.3 | $65M | 42M | 1.55 | |
| Revance Therapeutics (RVNC) | 25.3 | $54M | 3.3M | 16.23 | |
| Axogen (AXGN) | 20.3 | $44M | 2.4M | 17.89 | |
| Venus Concept | 15.4 | $33M | 7.0M | 4.70 | |
| Tela Bio (TELA) | 4.7 | $10M | 769k | 12.95 | |
| MediciNova (MNOV) | 3.5 | $7.5M | 1.1M | 6.74 | |
| Endologix | 0.3 | $717k | 126k | 5.70 | |
| Catalyst Biosciences | 0.2 | $535k | 79k | 6.80 |
